Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 115
Filter
1.
Rev Sci Instrum ; 85(11): 11E811, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25430376

ABSTRACT

A control system for a fast steering mirror has been newly developed for the electron cyclotron heating (ECH) launchers in the large helical device. This system enables two-dimensional scan during a plasma discharge and provides a simple feedback control function. A board mounted with a field programmable gate array chip has been designed to realize feedback control of the ECH beam position to maintain higher electron temperature by ECH. The heating position is determined by a plasma diagnostic signal related to the electron temperature such as electron cyclotron emission and Thomson scattering.

2.
Rev Sci Instrum ; 83(10): 10D731, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23126903

ABSTRACT

Collective Thomson scattering (CTS) diagnostic requires a strong probing beam to diagnose a bulk and fast ion distribution function in fusion plasmas. A mega-watt gyrotron for electron cyclotron resonance heating is used as a probing beam in the large helical device. Spurious mode oscillations are often observed during the turning on/off phase of the modulation. The frequency spectra of the 77-GHz gyrotron output power have been measured, and then one of the spurious modes, which interferes with the CTS receiver system, is identified as the TE(17,6) mode at the frequency of 74.7 GHz. The mode competition calculation indicates that the increase of the magnetic field strength at the gyrotron resonator can avoid such a spurious mode and excite only the main TE(18,6) mode. The spurious radiation at the 74.7 GHz is experimentally demonstrated to be suppressed in the stronger magnetic field than that optimized for the high-power operation.

3.
Diabetologia ; 55(11): 2913-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22854890

ABSTRACT

AIMS/OBJECTIVE: Nephropathy, a major complication of diabetes, is the leading cause of end-stage renal disease. Recent studies have demonstrated that podocyte injury is involved in the onset of and progression to renal insufficiency. Here, we describe a novel, highly sensitive ELISA for detecting urinary podocalyxin, a glycoconjugate on the podocyte apical surface that indicates podocyte injury, particularly in the early phase of diabetic nephropathy. METHODS: Urine samples from patients with glomerular diseases (n = 142) and type 2 diabetes (n = 71) were used to quantify urinary podocalyxin by ELISA. Urine samples were obtained from 69 healthy controls for whom laboratory data were within normal values. Podocalyxin was detected in urine by immunofluorescence, immunoelectron microscopy and western blotting. RESULTS: Morphologically, urinary podocalyxin was present as a vesicular structure; western blotting showed it as a positive band at 165-170 kDa. Levels of urinary podocalyxin were elevated in patients with various glomerular diseases and patients with diabetes. In patients with diabetes, urinary podocalyxin was higher than the cut-off value in 53.8% patients at the normoalbuminuric stage, 64.7% at the microalbuminuric stage and 66.7% at the macroalbuminuric stage. Positive correlations were observed between urinary podocalyxin levels and HbA(1c), urinary ß(2) microglobulin, α(1) microglobulin and urinary N-acetyl-ß-D-glucosaminidase, although urinary podocalyxin levels were not correlated with other laboratory markers such as blood pressure, lipid level, serum creatinine, estimated GFR or proteinuria. CONCLUSIONS/INTERPRETATION: Urinary podocalyxin may be a useful biomarker for detecting early podocyte injury in patients with diabetes.


Subject(s)
Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/urine , Enzyme-Linked Immunosorbent Assay/methods , Podocytes/metabolism , Sialoglycoproteins/urine , Adult , Aged , Antibodies, Monoclonal , Antibody Specificity , Biomarkers/urine , Blotting, Western , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/urine , Early Diagnosis , Female , Humans , Kidney Glomerulus/metabolism , Kidney Glomerulus/pathology , Kidney Glomerulus/ultrastructure , Male , Microscopy, Immunoelectron , Middle Aged , Podocytes/pathology , Podocytes/ultrastructure , Proteinuria/diagnosis , Proteinuria/urine , Sensitivity and Specificity , Sialoglycoproteins/immunology
4.
Phys Rev Lett ; 103(22): 225002, 2009 Nov 27.
Article in English | MEDLINE | ID: mdl-20366101

ABSTRACT

Record-breaking high power coherent radiation at a subterahertz frequency region from a gyrotron utilizing second harmonic resonance modes was attained with a simple cavity. In order to aim at high power and high frequency simultaneously, the oscillation mode was selected carefully enough to realize stable radiation free from mode competition. The cavity radius was determined from the viewpoints of the oscillation frequency, the coupling coefficient between the electron beam, and the rf-electric field. The cavity length was also optimized for the highest perpendicular efficiency. In addition, a new electron gun which is capable of generating a thin laminar beam for a large current was introduced. Consequently, single mode second harmonic radiation with powers of 52 and 37 kW at frequencies of about 349 and 390 GHz, respectively, was achieved.

5.
J Clin Pathol ; 59(3): 328-30, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16505288

ABSTRACT

OBJECTIVE: Aberrant expression of maspin protein related to DNA hypomethylation in the promoter region is frequently observed in gallbladder carcinomas, whereas the non-tumorous gallbladder epithelium is maspin negative. We investigated maspin expression in non-tumorous gallbladder epithelium in patients with cholelithiasis. METHODS: An immunohistochemical study of maspin expression was performed in 69 patients with cholelithiasis and 30 patients with gastric cancer without cholelithiasis. RESULTS: Immunoreactivity for maspin was observed in focal and patchy regions of the gallbladder epithelium. Positive immunoreactivity for maspin was significantly associated with the presence of intestinal metaplasia in patients with cholelithiasis (p<0.05). CONCLUSION: The high incidence of aberrant maspin expression in both intestinal metaplasia and carcinoma of the gallbladder supports the assumption that intestinal metaplasia of the gallbladder may predispose to gallbladder carcinoma.


Subject(s)
Biomarkers, Tumor/analysis , Cholelithiasis/chemistry , Gallbladder/chemistry , Serpins/analysis , Adult , Case-Control Studies , Cholelithiasis/pathology , Disease Progression , Endothelium/chemistry , Endothelium/pathology , Female , Gallbladder/pathology , Genes, Tumor Suppressor , Humans , Immunohistochemistry/methods , Intestinal Mucosa/pathology , Male , Metaplasia , Middle Aged , Stomach Neoplasms/chemistry
6.
Dis Esophagus ; 19(1): 48-52, 2006.
Article in English | MEDLINE | ID: mdl-16364045

ABSTRACT

Most esophageal carcinosarcomas are diagnosed as so-called carcinosarcoma, in which individual elements may be derived from a single common ancestor cell, and there have been a few reports describing true carcinosarcoma originating from two individual stem cells. We describe a case of esophageal carcinosarcoma exhibiting neoplastic osteoid formation. Immunoreactivity for vimentin and p53 was limited to only the sarcomatous component and was absent in the carcinomatous component. Furthermore, a point mutation in exon 7 of the p53 gene was observed only in the sarcomatous component. Both sarcoma and carcinoma cells distinctively metastasized to different lymph nodes. These observations led us to diagnose the esophageal tumor as a true carcinosarcoma.


Subject(s)
Carcinosarcoma/genetics , Carcinosarcoma/pathology , Esophageal Neoplasms/genetics , Esophageal Neoplasms/pathology , Genes, p53 , Point Mutation , Carcinosarcoma/surgery , DNA, Neoplasm/genetics , Esophageal Neoplasms/surgery , Fatal Outcome , Genes, p53/genetics , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/radiotherapy
7.
Br J Cancer ; 92(6): 1130-6, 2005 Mar 28.
Article in English | MEDLINE | ID: mdl-15770218

ABSTRACT

To seek for a candidate gene that would regulate tumour progression and metastasis in gastric cancer, we investigated gene expression profiles by using DNA microarray. Tumour tissue and adjacent normal tissue were obtained from 21 patients with gastric cancer and then examined for their gene expression profiles by the Gene Chip Human U95Av2 array, which includes 12 000 human genes and EST sequences. A total of 25 genes were upregulated and two genes were downregulated by at least four-fold in the tumour tissue. In a further analysis according to lymph node metastasis, the expressed levels of maspin, as well as carcinoembryonic antigen and nonspecific crossreacting antigen were significantly higher in tumours with lymph node metastasis than in those without it. Maspin expression in 85 gastric cancer patients was further investigated by using immunohistochemistry. Maspin expression was not observed in normal gastric epithelia without intestinal metaplasia. In contrast, maspin was expressed in 74 of 85 tumour tissues. There was a significant correlation between the incidence of maspin-positive tumour staining and lymph node metastasis. These results suggest that maspin has a potential role for tumour metastasis in gastric cancer.


Subject(s)
Gene Expression Profiling , Serpins/genetics , Stomach Neoplasms/genetics , Adult , Aged , Aged, 80 and over , DNA Methylation , Female , Genes, Tumor Suppressor , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , Promoter Regions, Genetic , Serpins/analysis , Stomach Neoplasms/pathology
8.
Acta Neuropathol ; 103(3): 288-94, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11907810

ABSTRACT

A 65-year-old woman was admitted to our hospital for forgetfulness, depression and eccentric behavior that had been first noticed 2 years prior to admission. She showed memory impairment, perseveration and repeated violent actions, but no limb-kinetic apraxia. She died 12 years after the onset of symptoms. At autopsy, the unfixed brain weighed 820 g. Atrophy was circumscribed in the frontal lobe on both sides. The globus pallidus and the caudate nucleus were markedly atrophic and gold yellow in color, and the substantia nigra was strikingly pale. The cortical area showed neuronal loss and status spongiosus of the second and third cortical layers with ballooned neurons. Marked neuronal loss was observed in the dorsomedial nucleus of the thalamus, Meynert basal nucleus and substantia nigra. With Holzer stain, fibrillary gliosis was found to be severe in the frontal lobe, globus pallidus, subthalamic nucleus, hippocampus, dorsomedial nucleus of thalamus, substantia nigra, pontine tegmentum and inferior olivary nucleus. With Bielschowsky-Hirano stain, neurofibrillary tangles were observed in the cortex, hippocampus, substantia nigra, dentate nucleus, subthalamic nucleus, pontine nucleus, the inferior olivary nucleus, dorsomedial nucleus of the thalamus and, to a lesser extent, the neostriatum. Strikingly numerous argyrophilic and tau-positive threads were present in the cerebral white matter. These neuropathological findings corresponded to corticobasal degeneration, but lesions characteristic of progressive supranuclear palsy were also found. Moreover, widespread iron deposition throughout the central nervous system was the most striking finding of the present case. To our knowledge, such a case has not been reported in the literature to date.


Subject(s)
Basal Ganglia/diagnostic imaging , Basal Ganglia/pathology , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Iron Overload/diagnostic imaging , Iron Overload/pathology , Neurodegenerative Diseases/diagnostic imaging , Neurodegenerative Diseases/pathology , Female , Humans , Iron Overload/complications , Middle Aged , Neurodegenerative Diseases/complications , Radiography
9.
Biochemistry ; 40(46): 14089-97, 2001 Nov 20.
Article in English | MEDLINE | ID: mdl-11705402

ABSTRACT

Activation of the phagocyte NADPH oxidase, a superoxide-generating enzyme, involves assembly of cytosolic p47(phox), p67(phox), and rac with the membrane-associated cytochrome b(558). Following cell-free activation, enzymatic activity is highly labile [Tamura, M., Takeshita, M., Curnutte, J. T., Uhlinger, D. J., and Lambeth, J. D. (1992) J. Biol. Chem. 267, 7529-7538]. In an attempt to stabilize the activity and to investigate the nature of the complex, we have produced fusion proteins between rac and a C-terminal truncated form of p67(phox) (residues 1-210, 67N), which is a minimal active fragment. In a cell-free system, a fusion protein 67N-rac had higher activity and a 3-fold higher affinity than the individual cytosolic proteins, and 67N-Ser3-rac, which has a longer linker, showed a similar activity with the individual proteins. In contrast, rac-67N, a fusion in the opposite orientation, showed considerably lower activity. The enzyme activity reconstituted with 67N-rac showed a 10-fold higher stability and a lower K(m) for NADPH than the individual components. In the absence of p47, 67N-rac fusion protein at a high concentration showed nearly full activation, which was higher than that with the individual components. These results indicate that covalent binding between p67N and rac in the correct order produces a more stable complex than the individual components, suggesting that interactions among the subunits significantly influence the duration of the oxidase activation. On the basis of these findings, we propose a model for the topology among rac, 67N, and cytochrome b(558).


Subject(s)
NADPH Oxidases/metabolism , Peptide Fragments/genetics , Phosphoproteins/genetics , Phosphoproteins/metabolism , Recombinant Fusion Proteins/metabolism , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism , Cell-Free System , Cytochrome b Group/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/genetics , Enzyme Stability/genetics , GTP Phosphohydrolases/metabolism , Half-Life , Humans , Neutrophils/enzymology , Neutrophils/metabolism , Peptide Fragments/metabolism , Peptide Fragments/physiology , Phosphoproteins/physiology , Recombinant Fusion Proteins/chemical synthesis , Superoxides/metabolism , Time Factors , rac GTP-Binding Proteins/physiology
11.
J Clin Neurosci ; 8 Suppl 1: 82-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11386833

ABSTRACT

PURPOSE: Venous ischaemia is diagnosed by angiography and estimated with SPECT and PET. But venous ischaemia presents different features due to aetiology, type of onset, time course and collateral circulation. The purpose of this study was to analyse and to classify VI with MRI. METHODS: An analysis of 12 cases of dural arteriovenous fistula (DAVF) with venous ischaemia, 4 cases of sinus thrombosis, and a case of cortical venous thrombosis was performed. Venous ischaemia is classified with MRI as Type 1: no abnormality, Type 2: T2WI showed high signal intensity area and Gd-MRI showed no enhancement, Type 3: T2WI showed high signal intensity area and Gd-MRI showed enhancement, Type 4: venous infarction or haemorrhage. RESULTS: Type 1 was 8 cases. Type 2 was 3 cases and indicated cytotoxic oedema. Type 3 was 2 cases and indicated vasogenic oedema because of the destruction of blood brain barrier. Type 4 was 4 cases. CONCLUSIONS: The classification may be a useful indicator of severity of venous ischaemia and treatment.


Subject(s)
Brain Ischemia/classification , Cerebral Veins/pathology , Magnetic Resonance Imaging , Sinus Thrombosis, Intracranial/pathology , Adult , Aged , Aged, 80 and over , Blood-Brain Barrier , Brain Edema/diagnosis , Brain Ischemia/diagnosis , Brain Ischemia/etiology , Brain Ischemia/pathology , Central Nervous System Vascular Malformations/complications , Central Nervous System Vascular Malformations/pathology , Cerebral Angiography , Cerebrovascular Circulation , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Sinus Thrombosis, Intracranial/complications , Venous Thrombosis/complications , Venous Thrombosis/pathology
12.
Hepatol Res ; 20(1): 97-113, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11282489

ABSTRACT

In order to clarify angiogenic mechanism in biliary tract carcinoma, expressions and functions of basic fibroblast growth factor (bFGF) and its receptors (FGFR-1-4), and vascular endothelial growth factor (VEGF) and its receptors were investigated by using human biliary tract carcinoma cell lines (KMC-1, KMC-2, KMBC and KMG-C). Expression of bFGF was confirmed in KMC-1 and KMC-2, and that of FGFR-1-4 in all the cell lines except no FGFR-2 in KMC-2. Expression of VEGF was detected in all the cell lines, whereas the cell lines did not express VEGF receptors. Addition of anti-bFGF neutralizing antibody to the medium did not suppress cell proliferation, whereas exogenous bFGF with or without heparin accelerated cell proliferation in all cell lines. Addition of anti-bFGF neutralizing antibody or anti-VEGF neutralizing antibody to the co-culture of human umbilical vascular endothelial cells (HUVEC) and KMC-2 suppressed the proliferation of HUVEC. Surgically obtained cholangiocarcinoma tissues (n=7) were immunohistochemically negative to bFGF, while six of the seven were positive to VEGF. These findings suggested that human biliary tract carcinoma cells express both bFGF and VEGF not as autocrine growth factors but as angiogenic factors. On the other hand, expression of VEGF was found at a higher frequency than bFGF both in the cell lines and tissues.

13.
Int J Oncol ; 18(2): 257-64, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11172590

ABSTRACT

Expression and functions of interleukin (IL)-8, a pro-inflammatory cytokine with angiogenesis action, was examined in 23 surgically resected hepatocellular carcinoma (HCC) specimens and 7 HCC cell lines. In all HCC tissues, IL-8 expression was confirmed with reverse-transcription polymerase chain reaction method and enzyme-linked immunosorbent assay, and immunohistochemistry showed HCC cells were the major producer of IL-8 in the tissues. Microvessel density was measured by the double immunohistochemical staining of muscular vessels in HCC tissues, but the density was not related to the level of IL-8 in the HCC tissues. On the other hand, in the co-culture of human umbilical vein endothelial cells (HUVEC) and a HCC cell line (KIM-1), IL-8 produced by KIM-1 significantly accelerated the proliferation of HUVEC. In addition, cases with a high IL-8 level in cancerous tissue had a significantly higher frequency of portal vein invasion, venous invasion and bile duct invasion (p<0.05). In the cultures of 7 HCC cell lines IL-8 secretion into culture medium increased with the treatment of IL-1beta or tumor necrosis factor-alpha. This showed IL-8 expression is regulated by inflammatory cytokines. IL-8 produced by HCC is an angiogenesis factor of HCC, but it could have a much more important role in the invasion and metastasis of HCC.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Endothelium, Vascular/metabolism , Interleukin-8/metabolism , Liver Neoplasms/metabolism , Neoplasm Proteins/metabolism , Aged , Angiogenesis Inducing Agents/metabolism , Carrier Proteins/drug effects , Carrier Proteins/metabolism , Coculture Techniques , Cytokines/pharmacology , Endothelial Growth Factors/metabolism , Endothelium, Vascular/drug effects , Female , Humans , Intercellular Signaling Peptides and Proteins , Interleukin-8/physiology , Lymphokines/drug effects , Lymphokines/metabolism , Male , Middle Aged , Neoplasm Proteins/physiology , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
14.
Dis Esophagus ; 14(3-4): 197-201, 2001.
Article in English | MEDLINE | ID: mdl-11869319

ABSTRACT

The objective of this study was to evaluate the therapeutic usefulness of chemoradiotherapy (CRT) followed by surgery in patients with clinically T4 (cT4) esophageal cancer involving adjacent organs such as the trachea, main bronchi, and large vessels. Thirty-seven patients with cT4 squamous cell carcinoma of the thoracic esophagus were enrolled in this study. The CRT regimen comprised cisplatin (70 mg/m2) on day 1, 5-fluorouracil (700 mg/m2) on days 1-4 and external irradiation (200 cGy/day, total 30 Gy) on either days 8-26 (sequential schedule, n=15) or days 1-19 (concurrent schedule, n022). Two courses of CRT were given. The results of CRT were complete response in nine patients, partial response in 19, no change in three (minor response in two), and progressive disease in six patients. The median response duration in all responders was 172 days (range: 56-2469, n=19). After CRT, 13 patients received surgery. In 12 of these patients, tumors were completely resected. Histopathologic examination of the resected specimen revealed a discrepancy between clinical response and histopathologic effect. The median duration of survival and the 1-, 2- and 5-year survival rates were 304 days (84-3155), 45%, 35% and 23% in all patients, respectively, 866 days (190-3155), 83%, 83% and 57% in the 13 patients whose tumors were resected, and 187 days (84--2630), 25%, 5% and 5% in the 24 patients whose tumors were not resected. Grade 3 toxicity, especially hematological reactions, was noted in 13.5% (5/37) of the patients. There was one toxicity-related death (sepsis). A good outcome may be obtained with CRT, followed by surgery when feasible. However, CRT can cause toxic reactions, and close monitoring of patients is required.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Squamous Cell/therapy , Esophageal Neoplasms/therapy , Neoplasms, Multiple Primary/therapy , Aged , Biopsy, Needle , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Cisplatin/administration & dosage , Combined Modality Therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Esophagectomy/methods , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Staging , Neoplasms, Multiple Primary/mortality , Neoplasms, Multiple Primary/pathology , Radiation Dosage , Statistics, Nonparametric , Survival Analysis , Thorax , Treatment Outcome
15.
Mod Rheumatol ; 11(3): 210-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-24383728

ABSTRACT

Abstract To evaluate the usefulness of a dipyridamole stress thallium-201 (Tl-201) perfusion scan in detecting myocardial involvement in systemic sclerosis we performed Tl-201 scans, electrocardiograms (ECG), and echocardiograms (UCG) on 24 patients with systemic sclerosis (11 diffuse type, 13 limited type) sequentially selected randomly over an 8-month period, and compared the findings. Cardiac catheterization, coronary angiography (CAG), and right ventricular endomyocardial biopsy were performed as necessary. Of the 24 patients, Tl-201 scans revealed fixed defects (FDs; myocardial fibrosis) and/or reversible defects (RDs; myocardial ischemia) in nine patients, whereas ECG and UCG revealed defects in four and three patients, respectively. Biopsy specimens obtained from the three patients with FDs also showed both ECG and UCG abnormalities indicative of myocardial fibrosis despite their normal appearance with CAG. Autopsy findings on the heart of a patient who died of acute heart failure showed myocardial fibrosis predominantly in the left anteroposterior wall. This was consistent with the FDs area detected using the Tl-201 perfusion scan. In a patient with chronic heart failure, left ventriculography showed a decrease in the anterior wall motion of the left ventricle which coincided with the FDs area in the Tl-201 perfusion scan. In conclusion, dipyridamole stress Tl-201 scanning is useful for evaluating myocardial involvement in systemic sclerosis.

16.
Int J Mol Med ; 6(6): 621-7, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11078820

ABSTRACT

Type I interferon (IFN) receptor consists of two chains (Hu-IFN-alphaR1 and Hu-IFN-alphaR2), and Hu-IFN-alphaR2 takes a soluble, short, or long form (Hu-IFN-alphaR2a, Hu-IFN-alphaR2b, or Hu-IFN-alphaR2c, respectively). We examined Hu-IFN-alphaR2 expression in hepatocellular carcinoma (HCC) tissues and their corresponding non-cancerous (non-HCC) tissues. Immunohistochemically, Hu-IFN-alphaR2 expression was positive in 53 (77%) of 69 HCC tissues and in 61 (88%) of 69 non-HCC tissues. Hu-IFN-alphaR2 protein in tissue homogenates of HCC and non-HCC tissues obtained from 29 patients was measured by using ELISA kits, and the amount was 12.7+/-10.9 pg/mg protein in HCC tissue and 10.5+/-5.0 pg/mg protein in non-HCC tissue. Number of specimens in which Hu-IFN-alphaR2 level was 3 pg/mg protein or lower, or 20 pg/mg protein or higher, was one each for non-HCC, while it was 7 (24%) and 6 (21%) for HCC. RT-PCR analysis was done in 7 of the 29 HCC cases. It revealed both Hu-IFN-alphaR2a and Hu-IFN-alphaR2c were expressed in all HCC tissues and in 6 of the 7 non-HCC tissues, and Hu-IFN-alphaR2b was expressed in all HCC tissues and in 4 of the 7 non-HCC tissues. Because immunostaining intensity of Hu-IFN-alphaR2 tended to be higher in the areas with active inflammation, effects of inflammatory cytokines (IL-1alpha, IL-1beta, and TNF-alpha) on Hu-IFN-alphaR2 expression were examined on 11 HCC cell lines. As a result, TNF-alpha up-regulated Hu-IFN-alphaR2 expression in 7 of the 11 cell lines. In 3 of the 7 cell lines, up-regulation of Hu-IFN-alphaR2 on cell surface, as well as of the soluble form of Hu-IFN-alphaR2, was induced not only by TNF-alpha, but also by IL-1alpha or IL-1beta. In conclusion, both HCC and non-HCC tissues frequently express Hu-IFN-alphaR2c that is necessary for Type I IFN response. Hu-IFN-alphaR2 expression in HCC tissues is often attenuated or enhanced, and may be regulated by inflammatory cytokines.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , Liver/chemistry , Receptors, Interferon/biosynthesis , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Cytokines/pharmacology , Flow Cytometry , Gene Expression Regulation, Neoplastic/drug effects , Humans , Immunohistochemistry , Interleukin-1/pharmacology , Liver/metabolism , Liver/pathology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Membrane Proteins , RNA, Messenger/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Interferon alpha-beta , Receptors, Interferon/drug effects , Receptors, Interferon/genetics , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology
17.
J Biochem ; 128(3): 499-507, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10965051

ABSTRACT

Kumamolysin, a carboxyl proteinase from Bacillus novosp. MN-32, is characterized by its thermostability and insensitivity to aspartic proteinase inhibitors such as pepstatin, diazoacetyl-DL-norleucine methylester, and 1,2-epoxy-3-(p-nitro-phenoxy)propane. Here, its substrate specificity was elucidated using two series of synthetic chromogenic substrates: P(5)-P(4)-P(3)-P(2)-Phe*Nph (p-nitrophenylalanine: *cleavage site)-P(2)'-P(3)', in which the amino acid residues at the P(5)-P(2), P(2)' and P(3)' positions were systematically substituted. Among 74 substrates, kumamolysin was shown to hydrolyze Lys-Pro-Ile-Pro-Phe-Nph-Arg-Leu most effectively. The kinetic parameters of this peptide were K(m) = 41+/-5 microM, k(cat) = 176+/- 10 s(-1), and k(cat)/K(m) = 4.3+/-0.6 mM(-1) x s(-1). These systematic analyses revealed the following features: (i) Kumamolysin had a unique preference for the P(2) position. Kumamolysin preferentially hydrolyzed peptides having an Ala or Pro residue at the P(2) position; this was also observed for the pepstatin-insensitive carboxyl proteinase from Bacillus coagulans J-4 [J-4; Shibata et al. (1998) J. Biochem. 124, 642-647]. Other carboxyl proteinases, including Pseudomonas sp. 101 pepstatin-insensitive carboxyl proteinase (PCP) and Xanthomonas sp. T-22 pepstatin-insensitive carboxyl proteinase (XCP), preferred peptides having hydrophobic and bulky amino acid residue such as Leu at the P(2) position. (ii) Kumamolysin preferred such charged amino acid residues as Glu or Arg at the P(2)' position, suggesting that the S(2)' subsite of kumamolysin is occupied by hydrophilic residues, similar to that of PCP, XCP, and J-4. In general, the S(2)' subsite of pepstatin-sensitive carboxyl proteinases (aspartic proteinases) is hydrophobic in nature. Thus, the hydrophilic nature of the S(2)' subsite was confirmed to be a distinguishing feature of pepstatin-insensitive carboxyl proteinases from prokaryotes.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Norleucine/analogs & derivatives , Pepstatins/pharmacology , Aspartic Acid Endopeptidases/chemistry , Aspartic Acid Endopeptidases/drug effects , Bacteria/enzymology , Binding Sites , Chromatography, High Pressure Liquid , Epoxy Compounds/pharmacology , Escherichia coli/enzymology , Kinetics , Lysosomes/enzymology , Models, Chemical , Norleucine/pharmacology , Peptides/metabolism , Recombinant Proteins , Temperature
18.
Oncol Rep ; 7(4): 725-9, 2000.
Article in English | MEDLINE | ID: mdl-10854533

ABSTRACT

Flt-1 (VEGF receptor-1) and KDR/Flk-1 (VEGF receptor-2) are the high-affinity receptors for the angiogenesis factor, vascular endothelial growth factor (VEGF). VEGF expression has been confirmed in human hepatocellular carcinoma (HCC), and VEGF is thought to be involved in the angiogenesis within HCC tissues. However, expressions of VEGF receptors in HCC have not been reported. We immunohistochemically examined expressions and localizations of Flt-1 and KDR in 28 surgically resected HCC tissues. In non-cancerous area, Flt-1 and KDR were mainly found in macrophages including Kupffer cells; both receptors were found in vascular endothelial cells in the portal veins and arteries within portal tracts; and KDR was also found in some sinusoidal endothelial cells. In cancerous area, Flt-1 and KDR were found in some macrophages, and also in the endothelial cells of intratumoral blood vessels. In 25 moderately and/or poorly differentiated HCCs, KDR expression in the blood space endothelial cells was clear and continuous in 20 cases, and focal in 5 cases. These results suggest that there would be an angiogenesis mechanism via VEGF/Flt-1 or VEGF/KDR in HCC, and the VEGF/KDR system would take a more important role.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Neovascularization, Pathologic/pathology , Proto-Oncogene Proteins/analysis , Receptor Protein-Tyrosine Kinases/analysis , Receptors, Growth Factor/analysis , Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/surgery , Colonic Neoplasms/pathology , Endothelium, Vascular/pathology , Female , Hepatitis/pathology , Humans , Immunohistochemistry , Kupffer Cells/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/blood supply , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Macrophages/pathology , Male , Receptors, Vascular Endothelial Growth Factor , Vascular Endothelial Growth Factor Receptor-1
19.
Small Rumin Res ; 36(3): 241-249, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10781740

ABSTRACT

Effects of sevoflurane and isoflurane anesthesia in oxygen on clinical, cardiopulmonary, hematological, and serum biochemical findings were compared in sheep breathing spontaneously undergoing minor surgical operations during short-term (60-80min) or long-term (3-4h) anesthesia. All sheep were premedicated with atropine sulfate (0.1mg/kg) intramuscularly, and 10min later, induced to anesthesia by intravenous infusion of sodium thiopental (mean 14.1+/-3.4 S.D. mg/kg). After intubation, they were anesthetized with either isoflurane or sevoflurane in oxygen at a total gas flow rate of 1.5l/min. The results revealed that recovery time with sevoflurane was more rapid than with isoflurane. Respiration rates, tidal volume, minute ventilation and heart rates during sevoflurane anesthesia were similar to those during isoflurane anesthesia. The degree of respiratory acidosis during sevoflurane anesthesia was also similar to that during isoflurane anesthesia. There were no significant differences between sevoflurane and isoflurane anesthesia in hematological and serum biochemical values.

20.
Clin Neuropathol ; 19(2): 94-103, 2000.
Article in English | MEDLINE | ID: mdl-10749290

ABSTRACT

An autopsy case with clinically and molecular genetically diagnosed Huntington's disease (HD) accompanied with minimal non-specific neuropathological features was reported. When the patient was 45 years old, he had faulty memory, mood swing, personality change and agitation. Neurological and psychiatric examinations revealed choreoathetoid movements in limbs and trunk, generalized hyperreflexia and mental deterioration. However, cerebellar ataxia and muscle rigidity were not disclosed. Neuroimaging study did not show a definite atrophy of heads of caudate nuclei. Neuroacanthocytosis and Wilson's disease were ruled out by the peripheral blood examination and serum Cu and ceruloplasmin examination. At the age of 55 he died of pneumonia. Post-mortem examination revealed minimal non-specific neuropathological features for HD (Vonsattel's grade 0), that is, no visible fibrillary gliosis in the striatum, and few neuronal loss and only proliferation of astrocytes (astrocytosis) in the striatum. Molecular-genetic study the patient's brain tissues and his youngest son's blood was performed. These studies revealed 40 CAG repeats in the patient, 56 CAG repeats in his youngest son. These results suggest they may be HD. Vonsattel et al. [ 1998] insist that grade 0 comprises 1% of all HD brains, and grade 1 comprises 4% of all HD brains. But we could not find any reports in which the clinical and neuropathological features were described in detail on the cases with clinically and molecular genetically diagnosed HD without specific pathological findings. Therefore, we present in detail the clinical and neuropathological features of such case.


Subject(s)
Brain/pathology , Huntington Disease/pathology , Chromosome Aberrations/genetics , Chromosome Disorders , Genes, Dominant/genetics , Humans , Huntingtin Protein , Huntington Disease/diagnosis , Huntington Disease/genetics , Male , Middle Aged , Nerve Tissue Proteins/genetics , Neurologic Examination , Nuclear Proteins/genetics , Pedigree , Polymerase Chain Reaction , Polymorphism, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...